Company Registration No. 08869313 (England and Wales)
HS Pharma Limited
Filleted accounts
for the year ended 31 January 2024
HS Pharma Limited
Filleted accounts
Contents
HS Pharma Limited
Company Information
for the year ended 31 January 2024
Director
Mr Sarfraz M Patel
Company Number
08869313 (England and Wales)
Registered Office
43 Seagrave Drive
Oadby
Leicester
Leicestershire
LE2 5GJ
England
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
HS Pharma Limited
Statement of financial position
as at 31 January 2024
Cash at bank and in hand
6,039
105
Creditors: amounts falling due within one year
(120,888)
(38,426)
Net current (liabilities)/assets
(70,169)
279
Called up share capital
100
100
Profit and loss account
18,325
179
Shareholders' funds
18,425
279
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 April 2025 and were signed on its behalf by
Mr Sarfraz M Patel
Director
Company Registration No. 08869313
HS Pharma Limited
Notes to the Accounts
for the year ended 31 January 2024
HS Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 08869313. The registered office is 43 Seagrave Drive, Oadby, Leicester, Leicestershire, LE2 5GJ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
4
Investments
Other investments
Valuation at 1 February 2023
-
Valuation at 31 January 2024
88,594
Amounts falling due within one year
Amounts falling due after more than one year
Amounts due from group undertakings etc.
44,680
-
HS Pharma Limited
Notes to the Accounts
for the year ended 31 January 2024
6
Creditors: amounts falling due within one year
2024
2023
Bank loans and overdrafts
2,920
4,421
Taxes and social security
2,849
14,814
Other creditors
102,959
13,269
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
8
Average number of employees
During the year the average number of employees was 2 (2023: 2).